The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer (PANDORA).
 
Stefano Tamberi
No Relationships to Disclose
 
Elisa Grassi
No Relationships to Disclose
 
Maria aurelia Barbera
No Relationships to Disclose
 
Jody Corbelli
No Relationships to Disclose
 
Giorgio Papiani
No Relationships to Disclose
 
Isacco Montroni
No Relationships to Disclose
 
Maria Di Bartolomeo
No Relationships to Disclose
 
Stefano Cascinu
Honoraria - Lilly; Lilly; Lilly; Lilly; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Lilly; Lilly; Lilly; Lilly; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Lilly; Lilly; Lilly; Lilly; SERVIER; SERVIER; SERVIER; SERVIER
Research Funding - Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly
 
Marina Marzola
No Relationships to Disclose
 
Andrea Bonetti
No Relationships to Disclose
 
Giovanni Frassineti
No Relationships to Disclose
 
Carmine Pinto
No Relationships to Disclose
 
Chiara Zingaretti
No Relationships to Disclose
 
Oriana Nanni
No Relationships to Disclose
 
Chiara Carli Moretti
No Relationships to Disclose
 
Ilaria Panzini
No Relationships to Disclose
 
Giulio Rossi
No Relationships to Disclose
 
Giampaolo Ugolini
No Relationships to Disclose